Memphasys visit Monash IVF. Cementing our clinical partnership

Dr David Ali, Director of Operations of Memphasys, recently visited the Monash IVF team in Melbourne, marking a pivotal…

Read More

Advancing Partnership: Memphasys Director of Operations Visits Manufacturing Partner Ahead of Major Orders

Memphasys Associate Professor Hassan Bakos PhD MBA, our Director of Operations, paid a visit to our FelixTM device…

Read More

Advancing Artificial Insemination: The AI-Port Spring Trial Shows Promise

Innovations in artificial insemination (AI) are revolutionising the breeding industry, and Memphasys is at the…

Read More

The gathering storm: One in twenty men are infertile

"The human male was not a very fertile individual. Roughly one in 20 is infertile ... An old lecturer of mine used to…

Read More

Memphasys progresses freeze-free semen transporter

Reproductive technology company Memphasys has announced findings from a trial at a stud farm of its semen storage and…

Read More

Watch: The future of infertility treatment

Dr Ramya Jayaram addressed ASPIRE 2023, the 12th Congress of the Asia Pacific Initiative on Reproduction, to present…

Read More

Memphasys Expands Global Reach: Exclusive Distribution Agreements Signed for Canada and New Zealand

In a significant stride towards global expansion, we have announced an exclusive distribution agreement with Vitrolife…

Read More

FelixTM: Viewpoint from Japan

As the first major global commercial agreement to sell and distribute the FelixTM sperm separation device goes from…

Read More

Image of blue spermatoza image held in hands

Memphasys accelerates commercial approval for sperm-separation device

Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…

Read More

Why FelixTM is big in Japan 

Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife…

Read More